Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 9,506Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Melinta Therapeutics

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DELAFLOXACIN MEGLUMINE

Brand Name : BAXDELA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 450MG BASE

Packaging :

Approval Date : 2017-06-19

Application Number : 208610

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DELAFLOXACIN MEGLUMINE

Brand Name : BAXDELA

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 300MG BASE/VIAL

Packaging :

Approval Date : 2017-06-19

Application Number : 208611

Regulatory Info : RX

Registration Country : USA

blank